ELTX vs IP · $132.3M cap vs P/E 43, rev $6.01B
Elicio Therapeutics Inc. (ELTX) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported ELTX revenue for 2023-03-31 was $0. Net income was -$8.0M. Revenue was down 100.0% from 2022-12-31 to 2023-03-31. ELTX currently screens at market cap $132.3M.
Latest reported IP revenue for 2025-12-31 was $6.01B. Net income was -$2.38B. Revenue was up 53.1% from 2024-12-31 to 2025-12-31. IP currently screens at market cap $26.62B and trailing P/E 43.1.
ELTX currently screens at market cap $132.3M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the ELTX and IP stock pages for the full models.
Not investment advice.